Garced, S. v. United Cerebral Palsy

2023 Pa. Super. 257, 307 A.3d 103
Superior Court of Pennsylvania·Decided December 7, 2023·No. 111 EDA 2022·Published·Cited by 9 cases

Opinion

2023 PA Super 257

SAMUEL GARCED AND GLADYS IN THE SUPERIOR COURT DELGADO-GARCED OF PENNSYLVANIA

Appellants

v.

UNITED CEREBRAL PALSY OF PHILADELPHIA AND VICINITY A/K/A BLOSSOM PHILADELPHIA AND SANOSIL USA, LLC AND SANOSIL INTERNATIONAL, LLC AND HALOSIL INTERNATIONAL, LLC

Appellees No. 111 EDA 2022

Appeal from the Order Entered December 7, 2021 In the Court of Common Pleas of Philadelphia County Civil Division at No.: 171003536

BEFORE: STABILE, J., MCCAFFERY, J. and PELLEGRINI, J.* OPINION BY STABILE, J.: FILED DECEMBER 7, 2023 In this civil action, Appellants Samuel Garced (“Mr. Garced”) and Gladys Delgado-Garced (“Mrs. Garced”) allege that Mr. Garced suffered injuries from exposure to a disinfectant cleaner known as HaloSpray manufactured by Appellee Halosil International, Inc.1 that was applied to a sealed room by employees of Appellee United Cerebral Palsy of Philadelphia (“UCP”) using a “fogger” provided by Halosil. Mr. Garced claimed that he suffered permanent

lung damage by inhaling HaloSpray fog that escaped through gaps between

* Retired Senior Judge assigned to the Superior Court.

1 Appellees Halosil International, Inc., Sanosil USA, LLC and Sanosil International, LLC fall under the same corporate umbrella. We refer collectively to these appellees as “Halosil.”

the sealed room and an adjacent room where he was cleaning. A jury awarded Mr. Garced $500,000.00 in damages for future medical expenses and $500,000.00 for past and future noneconomic loss but awarded no damages as to past lost earnings or future lost earning capacity. The trial court granted Halosil’s and UCP’s motions for judgment notwithstanding the verdict (“JNOV”) on Mr. Garced’s future medical expenses and future noneconomic loss based upon a failure to establish causation through competent expert testimony. The court denied Halosil’s motion seeking JNOV on the ground that Appellants’ action was preempted under the Federal Insecticide Fungicide Rodenticide Act (“FIFRA”), 7 U.S.C. § 136(v). The court ordered a new trial limited to the amount of past noneconomic loss related to Mr. Garced’s emergency room visits and follow-up treatment. Sanctions also were ordered as against Appellants and their counsel for conduct relating to the use of an interpreter at trial. Appellants appeal from the order disposing of post-trial motions. We affirm.

I. BACKGROUND FACTS AND APPEAL ISSUES.

The record reflects that HaloSpray consists of 94.5% deionized water, hydrogen peroxide, silver nitrate and phosphoric acid. Halosil, the manufacturer and seller of HaloSpray, provided a fogging machine (known as a HaloFogger) and bottles of HaloSpray to UCP. David St. Clair of Halosil trained Pat Bonner, head of UCP’s maintenance department, how to use the HaloFogger to generate disinfectant fog from HaloSpray and how to train other UCP employees to use the HaloFogger and prepare rooms for fogging. St.

Clair also trained another UCP employee, Jason Benson. St. Clair instructed that safe fogging requires closing all doors, sealing all gaps between the doors and door jambs and floors with masking tape, sealing all air vents and placing caution signs on exit doors to keep people out. St. Clair advised that nobody should enter a room that is being fogged without PPE (a respirator and goggles), and people without PPE should stay out until the next morning so that the hydrogen peroxide in the fog could dissipate.

UCP contracted with Mr. Garced to provide general cleaning services at UCP. On May 26, 2016, Mr. Garced was exposed to HaloSpray at UCP’s Philadelphia facility. On that date, Mr. and Mrs. Garced were providing cleaning services at UCP. When they arrived that day, they were told not to clean Room 166 that evening. Benson set up the HaloFogger in Room 166, sealed the room and left the building at around 8:30 to 8:45 p.m. Mr. Garced testified that he was mopping and sweeping the floor of the classroom adjacent to Room 166 when he began feeling symptoms in his nose, face and chest. He testified that he had been working for about twenty minutes in the room before noticing fog or smoke around him. When he looked up and saw smoke on the ceiling, he exited the room. In the hallway, his face was bright red, and he threw up a white substance. Mrs. Garced testified that the bathroom doors leading into Room 166 and the connecting room where Mr. Garced was working were both open at the time of the incident.

Appellants left UCP and drove to nearby Einstein hospital because Mr.

Garced was suffering from coughing and burning. He received oxygen in the

emergency room and reported chest pain and tightness. He claimed to never have had respiratory problems before the incident at UCP. Following the exposure incident, he related he had shortness of breath, coughing, pain in his chest, left-sided sinus pain and swelling.

In mid-August 2016, three months after the incident at UCP, Mr. Garced was diagnosed with irritant induced asthma or reactive airway disease syndrome (“RADS”). He later underwent sinus surgery, and he stopped working in 2019.

Appellants filed a personal injury action raising negligence claims against all Appellees as well as product liability and breach of warranty claims against Halosil. Appellants also named St. Clair as a defendant but later agreed to dismiss their claim against him. The court granted summary judgment in favor of Halosil on the product liability and warranty claims but permitted the case to proceed to trial on Appellants’ negligence claim.

Several weeks before trial, the parties filed a total of 24 motions in limine, including Halosil’s Frye2 motion to preclude the testimony of Appellants’ medical expert witnesses, Drs. Lazaar and Savul, on the ground that the methodology underlying their opinions was not generally accepted in the relevant scientific community. UCP subsequently joined in this motion. One day before trial, the case was reassigned from the Honorable Sean Kennedy to the Honorable James Crumlish, III. On the morning of trial, the

2 Frye v. United States, 293 F. 1013 (D.C. Cir. 1923).

parties argued the motions in limine before Judge Crumlish. Without holding an evidentiary hearing, Judge Crumlish denied the Frye motion without prejudice to Appellees’ right to renew their objections to the medical experts’ testimony during trial. N.T., 9/28/21, at 29.

The case proceeded to trial before Judge Crumlish. Appellants contended that Halosil was negligent in teaching UCP employees and in failing to identify places where the fog could escape and injure bystanders. Appellants asserted that UCP’s employees were negligent in failing to seal the room it was fogging. Drs. Lazaar and Savul testified that Mr. Garced’s exposure to HaloSpray was the cause of his RADS. Notably, Appellants did not present any testimony, expert or otherwise, concerning the concentration of fog in the room where Mr. Garced experienced symptoms, a calculation of the dosage of HaloSpray that he inhaled, or the concentration of the mist in the room that would have been sufficient to cause RADS.

Mr. Garced required an interpreter for his testimony because his primary language is Spanish. After trial began, Appellees learned that Appellants and their counsel met with their interpreter before and during trial to discuss Mr. Garced’s testimony. Appellees immediately moved for a directed verdict on the ground that Appellants and their counsel improperly coached the interpreter. The court denied this motion without prejudice to Appellees’ right to raise the same motion at the conclusion of trial.

At the close of Appellants’ case, the court entered a nonsuit against Mrs.

Free access — add to your briefcase to read the full text and ask questions with AI

Garced, S. v. United Cerebral Palsy, 2023 Pa. Super. 257, 307 A.3d 103 (Pa. Ct. App. 2023).

2023 Pa. Super. 257 (Garced, S. v. United Cerebral Palsy) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Melendez, D. v. Mo, G.
Superior Court of Pennsylvania, 2026
Maldonado, A. v. Wismer, D.
Superior Court of Pennsylvania, 2026
Marhunova, H. v. Fitler Construction Group
Superior Court of Pennsylvania, 2026
Borsari, D. v. Latrobe Area Hospital, Inc.
Superior Court of Pennsylvania, 2026
Bush, M. v. Adams, C.
Superior Court of Pennsylvania, 2025
Britcher, M. v. Erie Insurance Company
Superior Court of Pennsylvania, 2025
MORNEAULT v. LONGORIA
D. Maine, 2025
Galli, N. v. Odenigbo, V.
Superior Court of Pennsylvania, 2025
Jones, N. v. Foods on First
2025 Pa. Super. 184 (Superior Court of Pennsylvania, 2025)
Durst, R. v. Marom Gerritt, II, L.P.
Superior Court of Pennsylvania, 2025
Rosenberg, N. v. United Financial Casualty
Superior Court of Pennsylvania, 2025
Coryell, C. v. Morris, J.
2025 Pa. Super. 28 (Superior Court of Pennsylvania, 2025)
Garced, S. v. United Cerebral Palsy
2023 Pa. Super. 257 (Superior Court of Pennsylvania, 2023)